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Scleroderma (systemic sclerosis)  is a disorder of connective tissue affecting skin and 
a variety of internal organs (1, 2). Despite remarkable variation in the site, rate, and 
degree of involvement in the individual subject, tight skin is the clinical hallmark of 
the  disease.  Repeated studies  using a  variety of techniques  (histochemical, electron 
microscope,  and  biochemical)  have  failed  to  define  the  defect  in  skin  connective 
tissue;  its  etiology and pathogenesis  are  unknown  (3).  There  remains  considerable 
disagreement concerning the thickness of scleroderma skin (4),  the appearance of its 
connective tissue fibers (3),  and the relative extractability of collagen from it (5, 6). 
Promising studies  of both collagen and carbohydrate biochemistry either  have  not 
been confirmed or remain insufficiently characterized  (5,  7).  These direct studies  of 
skin biopsy material are limited by both technical and clinical considerations. 
Abnormalities of connective tissue that persist in cell culture could be approached 
from the standpoint of the nature  of the abnormal tissue and the mechanism of its 
development. Tissue culture techniques have been applied effectively to the metabolic 
study of both heritable (Hurler's syndrome, galactosemia, acatalasemia) and acquired 
(rheumatoid arthritis,  amyloidosis) disorders of man (8, 9). 
The present  study reports  the  establishment  in vitro of cell  strains  of skin 
fibroblasts  from subjects  with  scleroderma  paired  with  strains  from subjects 
with  normal  skin.  A  consistent  increase  in  soluble  collagen  was  observed  in 
scleroderma skin cell cultures.  Glycoprotein content,  estimated by hexosamine 
and  sialic  acid  determinations,  was  also increased.  Low levels  of uronic  acid 
were  observed.  These  are  the  basis  for  attributing  the  hexosamine  changes 
to glycoprotein, and they suggest that the scleroderma skin cells were not syn- 
thesizing  chondromucoprotein in quantity.  The  significance  of these  observa- 
tions  and  the  advantages  and  limitations  of  the  cell  culture  technique  are 
considered. 
Materials and Methods 
The cell culture  techniques were developed from  those  of the laboratory  of Dr.  C.  W. 
Castor, with his generous help  (9, 10). All reagents were of analytical  quality or higher. 
Culture Materials.--The media used to develop cell lines consisted of: CMRL-1066  (lyo- 
philized, reconstituted  in double-distilled water),  80%; fetal calf serum, 20%; and penicillin 
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(50/~g/ml), streptomycin (50/zg/ml), and L-glutamine (20 mu/ml)  (Grand Island Biological 
Co.,  Grand  Island,  N.  Y.).  Cells were cultured in  T-flasks with V  bottoms  (Bellco  Glass, 
Inc., Vineland, N. J.). Pronase (B grade), trypsin (0.25% sterile), and collagenase (CLS, 200 
units/rag) were obtained from Calbiochem, Los Angeles, Calif., Grand Island Biological Co., 
and Worthington Biochemical Corp.,  Freehold, N.  J., respectively. 
Skin Specimens.--Scleroderma skin was obtained by biopsy. Control skin was obtained at 
operation from subjects with no apparent skin disease. Control skin was matched with sclero- 
derma skin for the age and sex of the subject and the anatomic site from which the specimen 
was taken, with one exception (see Subjects Studied). 
Cell  C~dture Technlque.--For  primary  explants,  fresh  sterile  skin  was  cleaned  of  sub- 
cutaneous fat,  cut into  1-mm pieces,  placed in T-flasks under perforated cellophane sheets 
with media, and grown for 2-4 wk at 37°C in an atmosphere of 5% C02 and air. Explants were 
subcultured when a  "swirl"  of  fibroblasts appeared  around  each  explant.  Monolayer sub- 
cultures were obtained from explant cultures by treating the latter with trypsin (1 nlg/ml in 
balanced salt solution) at 37 ° for 540  rain to free cells from the glass surface.  Cells were 
separated by centrifugation and resuspended in growth media by repeated aspiration into a 
pipette. Monolayer cultures were grown in serum dilution bottles until the stationary phase of 
growth was  observed microscopically. 1 
Cell Cnllure Harvest.--After experimental periods of 7, 9, or 12 days, the stationary cultures 
were divided into media and cell fractions. The media were aspirated from the culture bottles, 
centrifuged to remove particulate matter, measured volumetrically, and stored at 4°C.  The 
cell monolayer was washed with saline, harvested with a rubber policeman, and homogenized 
at 0°C in 2 ml of saline with a DuaI1  tissue homogenizer with a  motor-driven pestle (Kontes 
Glass Co.,  Vineland, N. J.). Homogenization periods of  10-15  sec were alternated with  1-2- 
min cooling periods  to  prevent  local  heating.  Companion experiments were carried out to 
compare the use of cell counts and DNA measurements to estimate the cells present. After 
the media had been removed, the cell layer was treated with collagenase (1  mg/ml saline, 30 
min, 37°C), which dispersed the cells  uniformly and  allowed  reproducible counts in a  Neu- 
bauer hemocytometer (Neubauer Manufacturing Co.,  Minneapolis, Minn.). 
Media  and  Cell  Homogenate  Analyses.--The  media  were  analyzed  for  hydroxyproline, 
hexosamine, uronic acid, and sialic acid; the cell homogenates, for DNA and hydroxyproline, 
as follows: 
Hydroxyproline:  The procedure of Prockop and Udenfriend (12) was the primary technique 
used; all determinations were carried out in duplicate or triplicate and monitored for inter- 
fering materials at OD 450.  Selected samples were also assayed by the modified procedure of 
LeRoy et al. (13) to check for materials previously shown to interfere with authentic hydroxy- 
proline determination. The two procedures agreed within 5%; interfering material (OD 450) 
was  not observed.  In  separate  determinations, fetal calf serum  was found  to  contain only 
small quantities of the previously described collagen-like protein of serum  (13). 
DNA :  DNA was determined in the cell pellet as an estimate of cells by the procedure of 
Burton  (14).  The  standard  was  calf  thymus  DNA  (Pierce  Chemical  Co.,  Rockford,  Ill.), 
DNA was  not detectable in  the media. 
Ilexosamine, uronic acid,  and sialic acid:  The recognized interference of large quantities 
of protein was avoided by extensive digestion of the media with pronase (23°C,  72 hr, 125 #g 
enzyme/ml media) followed by separation of the carbohydrate-containing glycopeptide peak 
on a Sephadex G-25 column (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) with volatile 
buffers (15).  The carbohydrate-contalnlng excluded peak was lyophilized. Weighed aliquots 
were  used  for  carbohydrate  determinations. 
1 For this study the stationary phase is defined as the presence of both dividing (mitosis 
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Hexosamine:  Initial  determinations  were  carried  out  using  the  column  procedure  of 
Boas  (15) and the direct procedure of Swann and Balazs (17).  Using pronase-treated media, 
these procedures gave indistinguishable results; the Swarm and Balazs procedure was used 
routinely. All determinations were carried out in duplicate and were monitored for interfering 
material at OD 565. The standard was galactosamine (J. T. Baker Chemical Co., Phillipsburg, 
N. J.). 
Uronic  acid:  The  technique of Dische  (18)  was  used with pronase-treated media.  The 
standard was D-glucuronic acid  (J. T. Baker Chemical Co.). 
Siali¢  acid:  The procedure of Warren  (19)  was used,  with pronase-treated media.  The 
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FIG. 1. Plot of ceil count in relation to DNA determination in control and scleroderma cell 
cultures. The correlation coefficient (r) was 0.96.  The regression equation was y  =  0.08 x -t- 
(--  0.06).  See Materials and Methods for description of techniques. 
RESULTS 
Validity  of Procedures.--The  validity of DNA measurements as an estimate 
of cells  was confirmed by relating  DNA values  to  total  cell  counts  after  ex- 
tensive  digestion  with  collagenase  to  free  the  cells  from  the  extracellular 
matrix.  In Fig.  1,  cell  counts  are  plotted  against  DNA measurements;  there 
is a  linear correlation between the two (r =  0.96). DNA was used routinely as 
a measure of cells present in a monolayer culture; analyses for connective tissue 
components were  expressed  as a  function  of the DNA content  of the culture 
(20).  The data in Fig.  1 indicate  a  mean DNA level of 11-12 pg/cell,  a  value 
consistent with previous determinations  (21). 
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specimens were obtained are shown in Table I. Each  specimen of scleroderma 
skin obtained at biopsy was paired with a  sample of control skin matched for 
the  age and  sex of the donor and the anatomic site from which the  specimen 
was  taken.  Cultures  were  then  developed and  studied  in  identically handled 
pairs. An exception to the anatomic matching of biopsies was  an upper-thigh 
skin biopsy obtained from a  young man with scleroderma. This specimen was 
TABLE  I 
Clinical Data 
Age  Sex  Site  Operation 
yr 
Control (9)  20-57  8 F, 1 M  Wrist (8), forearm (1)  Varied* 
Scleroderma~ (9)  16-62  7 F, 2 M  Wrist (7), forearm  (1), thigh  Biopsy 
(1) 
* Procedures  from  which  normal skin was  obtained included: wrist fusion  for  trauma, 
ganglionectomy  (2),  median nerve release  for  carpel tunnel syndrome,  open  reduction of 
Colles' fracture  (2), tendon lysis for  DeQuervain's stenosing  tenosynovitis, synostosis  for 
paralytic  poliomyelitis,  and tenosynovectomy  for rheumatoid arthritis. 
J; All subjects had scleroderma  (systemic sclerosis), with involvement of the skin at the site 
of biopsy by both clinical and histologic criteria. 
TABLE  II 
Cell Culture Data 
Mean primary  Monolayer  Mean duration  explant culture  Experimental period  time  no.  of subcultures* 
days  (range)  Days  (range)  days 
Control (9):~  33  3.2  30.0  7  (3),  9  (2),  12  (4) 
(25-57)  (1-6)  (7-89) 
Scleroderma  (9)  30  2.3  35.3  7  (3),  9  (2),  12  (4) 
(21--40)  (1  4)  (7-80) 
* The mean duration of monolayer subcultures is the time from the original trypsin disper- 
sion of primary explants to the beginning of the experimental period. The total days divided 
by the number of subcultures gives the mean duration. 
2~ Number of cell cultures in each group. 
in all respects similar to the specimens from the wrists and forearms of sclero- 
derma subjects. The  indications for surgery in the control subjects are shown 
in Table I. Skin from control subjects was clinically and histologically normal. 
The skin of the biopsy site in all the scleroderma subjects was hidebound,  and 
histological findings were compatible with the diagnosis of scleroderma. 
Establishment  of  Cell  Cultures.--Parameters  of  cell  growth  are  shown  in 
Table II. The  time  required  to  establish primary explants was  similar in  the 
control and  scleroderma groups.  In the  monolayer subcultures,  however,  skin E.  CARWILE  LEROY  1355 
fibroblasts  from  scleroderma  subjects  required  slightly  longer  to  reach  the 
stage of confluence than did control cells (Table II) ;,consequently  , the duration 
of  the  subcultures  was  slightly  longer  and  the  number  of  subcultures  was 
slightly less in the  scleroderma  group. These qualitative  observations~ suggest 
that,  in these experiments,  scleroderma skin fibroblasts grew more slowly than 
control skin fibroblasts. Determinations of cell-doubling times are being carried 
out to study this possibility. 
Collagen Synthesis.--Hydroxyproline  determinations  were used as estimates 
of soluble  collagen  in  the  media  and  of insoluble  collagen in  the  cell  pellets, 
TABLE III 
Collagen Assay 
Soluble  Insoluble  Total 
Experiment 
1 (12 days)* 
2 (12 days) 
3 ( 9 days) 
4 (12 days) 
5 ( 7 days) 
6 (  7 days) 
7 ( 9 days) 
8 (12 days) 
9 ( 7 days) 
Mean +  SE~t 
P 
Control  Scleroderma 
0.5  4.0 
1.3  3.4 
~).8  2.9 
0.4  1.6 
0.3  1.2 
0.6  1.1 
0.2  1.1 
0.1  0.7 
1  0  0.6 
0,6  4- 0.1 1.8  ±  0.4 
<0.005 
Control  Scleroderma 
t~g hypro/#g  DNA* 
0.2  0.4 
0.4  1 •0 
0.2  0.4 
0.03  0.1 
0.5  1.4 
0.4  0.4 
0.4  0.2 
0,1  0.2 
0.3  ±  0.10.5  -4- 0.2 
NS§ 
Control  Scleroderma 
0.7  4.4 
1.7  4.4 
1.0  3.3 
0.3  1.3 
1.1  2.5 
0.6  1.5 
0.5  0.9 
1.1  0.8 
0.9  -4- 0.22.4  -4- 0.5 
<0.01 
* Expressed as  the net increase in hydroxyproline  per ~g DNA (media hydroxyproline 
subtracted)• 
Number of days cells were exposed to the particular  medium analyzed. 
§ NS, not significant at the 5% level, i.e., P  >  0.05. 
as  shown  in  Table  III.  Media  from  scleroderma  skin  fibroblasts  contained 
increased  quantities  of  soluble  collagen  in  eight  of nine  experiments,  the  in- 
crease ranging from 20  to 800%.  These  data  are  significantly different  (P  < 
0.005) from control measurements,  using Student's t test. 
Glycoprotein Synthesis.--The net increase in hexosamine and sialic  acid was 
determined  in  five  culture  pairs  as  an  estimation  of  glycoprotein  synthesis; 
these  data  are  shown in  Table  IV. In four  of five culture  pairs,  hexosamine 
and  sialic  acid  levels  were  significantly  higher  in  scleroderma  cell  culture 
media compared with control media. In no culture was there a  net decrease or 
"consumption"  of glycoprotein. 
Hexosamine  is  a  component  of both  glycoprotein  and  glycosaminoglycan; 
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low levels of uronic acid observed (Table IV). Although not as striking as the 
differences in collagen synthesis,  the increases  noted in glycoprotein synthesis 
in scteroderma cell cultures raise the question of abnormalities of a heterogene- 
ous  group  of  connective  tissue  glycoproteins  (acidic  structural  proteins)  in 
scleroderma. Because of inadequate material, insoluble glycoprotein synthesis in 
the cell pellet was not studied. 
Chondromucoprotein  Synthesis.--Uronic  acid was used as an indicator of the 
synthesis  of the glycosaminoglycan moiety of chondromucoproteins. Although 
four of five culture pairs showed increases in the scleroderma culture, increases 
and  differences in nronic acid production were  small.  The obvious interpreta- 
tion  that  glycosaminoglycan synthesis  is low could be in  error if the  cell  cul- 
tures  were  producing  primarily  dermatan  sulfate  (chondroitin  sulfate  B),  a 
TABLE IV 
Carbohydrate Assay 






Mean ±  sE~ 
P 
Control  Scleroderma 
69  17 
25  38 
13  41 
22  49 
29.0  ±  ±  6 
NS~ 
Control  I Scleroderma 
~g/~g DNA* 
3.8  ]12.9 
3.5  [ 4.8 
14.6  8.4 
1.5  5.6 
2.2  6.2 
5.1  ±  2.4  7.6  ±  1.5 
NS 
Control  Scleroderma 
1.4  58.4 
22.6  22.2 
20.0  47.2 
8.6  33.3 
20.3  51.6 
14.6  ±  4.142.5  4-  6.5 
<0.02 
* Net increase of each determination  (i.e., media level subtracted). 
++ NS, not significant at the 5% level, i.e., P  >  0.05. 
glycosaminoglycan found in  skin  whose uronic  acid gives approximately  one- 
third the color value of other uronic  acids  with the  Dische  method  (22).  Iso- 
lation and identification  of the glycosaminoglycans produced in these cultures 
will  be  necessary to  answer  this  question.  Insoluble  chondromucoprotein was 
not measured because of the inadequate  quantities  of cell pellet material. 
DISCUSSION 
In  this  report  scleroderma  skin  fibroblasts  in  vitro  have  been  shown  to 
synthesize  increased  amounts  of  collagen  and  glycoprotein  compared  with 
control skin fibroblasts.  Thus scleroderma joins an increasing number of both 
heritable  and  acquired  disorders  in  which  abnormalities  are  demonstrable  in 
cells propagated in vitro, which allows more precise study of the pathogenesis 
and, ultimately perhaps,  of the etiology of the disease. 
It is not surprising  that  cell  cultures from subjects  with  a  large number of 
inherited  disorders  have  been  shown to maintain  the phenotypic biochemical E.  CARWlLE  LEROY  13S7 
abnormality in the culture setting. These disorders include those in which a 
specific  enzyme deficiency accounts for the abnormality (acatalasemia, galac- 
tosemia)  and those in which the observed abnormality cannot be readily ex- 
plained by a single enzyme deficiency (Hurler's syndrome, Hunter's syndrome, 
cystic fibrosis  [8,  23]).  It  is  less  predictable  that  acquired  diseases,  such  as 
scleroderma,  would  maintain  demonstrable  abnormalities  in  tissue  culture 
conditions; nonetheless, a  precedent exists for such a  hypothesis. Castor has 
found that synovial fibroblasts from subjects with rheumatoid arthritis, con- 
sidered to be an acquired disorder, show increased hyaluronate synthesis, in- 
creased glucose uptake, and decreased suppression by glucocorticoids (9,  10). 
These abnormalities  persist  after  repeated  subcultures,  and can be  induced 
in normal synovial fibroblasts by a  connective tissue activating principle ob- 
tained from a  variety of normal tissues. Experimental amyloidosis is another 
acquired disorder in which the abnormality persists in tissue and organ culture. 
In mice stimulated to develop amyloidosis by hyperimmunization or casein ad- 
ministration, splenic explants were observed to deposit amyloid after 2-6 wk 
in an organ culture setting. Radioautographic localization of labeled tryptophan 
and/or leucine incorporation into the amyloid fibers confirmed the morphologic 
and tinctorial suggestions that amyloid was produced in vitro (24, 25). 
Although these  studies in the  acquired disorders rheumatoid arthritis  and 
amyloidosis provide a  precedent for the  present  observations of a  persistent 
increase  in collagen synthesis in scleroderma,  they do not shed light on the 
mechanism of the abnormalities observed. Among the tenable possibilities are 
the  selection of a  population of fibroblasts committed to  increased  collagen 
and  glycoprotein synthesis in  scleroderma  skin;  the  persistence  of increased 
connective tissue synthesis after the  original stimulus, possibly metabolic or 
nutrient, has been removed; or somatic mutation induced by unknown mecha- 
nisms. Most of the apparent hypotheses are amenable to direct experimental 
testing. 
The present observations of increased collagen synthesis are based on elevated 
levels  of hydroxyproline in  the  media.  Although this criterion has been  ex- 
tensively used by Green and Goldberg (26)  as evidence of newly synthesized 
collagen,  alternate  explanations  involving  the  degradation  of  collagen  and 
hydroxyproline are possible. Further studies of the role of specific mammalian 
collagenase in scleroderma are  contemplated. However, collagenase does not 
affect the capacity to detect hydroxyproline, and variations in collagenase ac- 
tivity would not alter the data of the present report. Man has the demonstrated 
capacity  to  degrade  hydroxyproline; a  study  of  enzymatic mechanisms  by 
Efron and associates (27),  stemming from the observation of a  child with ex- 
tremely high levels of free hydroxyproline in urine and blood, demonstrated 
the  degradative  pathway  from  hydroxyproline  to  hydroxyglutamic  acid. 
Whether such a  mechanism is operative in the present culture system is un- 
known; this question can be pursued experimentally. 
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in existing reports,  recent morphologic and metabolic data support  the con- 
tention that there  is  enhanced collagen synthesis in the  skin of scleroderma 
subjects.  Aside from the  direct data  of the  present  report,  the  morphologic 
studies  of several  laboratories provide the most compelling evidence of new 
collagen synthesis in scleroderma skin. Bahr (28) originally described an abnor- 
mal population of small-diameter collagen fibers in scleroderma in 1956. Subse- 
quent  independent studies  by Fisher  and  Rodnan  (29)  and,  more  recently, 
by Rupec and Braun-Falco (30)  have confirmed the presence  of these  small 
fibers; further, Hayes and Rodnan (31)  have, by negative-staining ultrastruc- 
tural techniques, observed a  beaded filament morphology of these  thin fibers 
that  is  characteristic  of embryonic collagen. This  observation,  coupled  with 
morphologic evidence of active protein synthesis in the scleroderma fibrocyte, 
led to the suggestion that collagen may well be synthesized in excess in  sclero- 
derma skin. 
Metabolic confirmation of these morphologic observations is, aside from the 
present  study, somewhat indirect. Two lines of indirect evidence by each  of 
two laboratories suggest increased collagen synthesis in scleroderma. First, an 
enzyme unique to collagen synthesis, protocollagen proline hydroxylase (which 
converts  peptide-bound  proline  into  hydroxyproline), is  enhanced in  sclero- 
derma skin.  This observation was made originally by Uitto  et  ah  (32)  and, 
independently, by Keiser et  ah  (33).  It is noteworthy that the latter group 
observed increased levels in skin from areas (parasacral)  that could represent 
uninvolved skin. A metabolic defect in both uninvolved and involved skin of 
scleroderma subjects has important implications for an understanding of the 
disease. It will be important to know if the data of the present report can be 
duplicated in clinically and histologically  normal skin from scleroderma subjects. 
The  second  line  of indirect  evidence  that  collagen synthesis is  increased  in 
scleroderma skin stems from observations of increased incorporation of labeled 
proline  by  skin  biopsy  material.  These  data  are  more  variable,  only some 
biopsies demonstrate increased uptake,  and collagen is  not the  only protein 
into which proline is incorporated.  Still, increased uptake has been observed 
by both Laitinen et al. (34) and Keiser and Sjoerdsma (35). 
Extraction studies of the solubility of collagen from scleroderma skin have 
given conflicting results.  Harris  and  Sjoerdsma  (5)  noted decreased concen- 
trations of acid-soluble collagen in both clinically involved and clinically normal 
skin of subjects with scleroderma. Subsequent studies have shown normal or 
increased  concentrations of neutral  salt-soluble collagen in scleroderma  skin 
biopsies when compared with skin samples from normal subjects (6, 36).  The 
most recent  of these  studies  demonstrated twofold increases  in  soluble  skin 
collagen in scleroderma patients 40-70 yr of age; 2-3 % of the total skin collagen 
of several patients was soluble in 0.45 z~ sodium chloride (6). The use of a high- 
speed mechanical homogenizer potentially capable of collagen denaturation is a 
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with increased collagen biosynthesis in  the skin of patients with scleroderma. 
The data of the present report are the first direct demonstration of increased 
collagen synthesis in scleroderma skin. 
The  tentative conclusion of the  present  study that  glycoprotein synthesis 
is  increased in  scleroderma skin fibroblast cultures is  based  on the  observed 
increases in sialic acid levels and the suggestive increases in hexosamine, with 
no change in uronic acid levels. Some caution regarding the conclusion stems 
from  the  well-documented  observation  that  iduronic  acid,  a  constituent  of 
dermatan sulfate, and its derivatives give as little as 20-30% of the color of an 
equivalent weight of glucuronic acid (22). The presence of unusual amounts of 
dermatan sulfate in the scleroderma cultures could mask differences in glycos- 
aminoglycan synthesis; isolation of the polysaccharide moieties will  be neces- 
sary to resolve this possible alternate explanation for the data of the present 
report. 
It is possible that the observed differences in extracellular matrix are related 
to general phenomena of cells propagated in cell culture.  From fundamental 
investigations of cells in culture,  it is felt that continued cell passage  selects 
those cells that revert to a less-differentiated (dedifferentiated) state (11, 37). 
Since collagen synthesis is considered to be a  function of differentiated fibro- 
blasts, the present data might be viewed as a  more rapid dedifferentiation of 
normal  fibroblasts,  leaving  scleroderma  fibroblasts  more  differentiated  and 
making more collagen. Were this the case, normal fibroblasts would be expected 
to produce more protein-polysaccharide, a characteristic of the dedifferentiated 
state.  Since four of five normal  cell  cultures  contained less  protein-polysac- 
charide than the scleroderma cultures, a more rapid dedifferentiation of normal 
skin fibroblasts is  not a  likely explanation for the present observations  (26). 
In this context, it is not possible to state the precise metabolic meaning of 
the  increases  in  soluble collagen noted in  the present study.  In  general,  the 
finding of increased soluble or extractable collagen has been most clearly linked 
to increased collagen synthesis (38), and the dense fibrosis of scleroderma skin 
provides  support  for  this  interpretation.  Experiments  designed  to  separate 
synthesis  from  degradation  will  be  necessary  to  answer  these  questions.  It 
will  also be of value to characterize the macromolecular structure of both the 
collagen and the polysaccharide produced by these cell lines. Of particular in- 
terest is the recent awareness that fibroblasts from normal human skin produce 
unusual  ratios of a-1 and ~-2  collagen subunits; moreover, up  to 80% of the 
soluble  hydroxyproline is  present  in  the  form  of  a  large  molecular  weight, 
protease-sensitive precursor of collagen a-chains, which may be important in 
the regulation of collagen biosynthesis (39). These findings by several labora- 
tories have led to the concept of "procollagen" as a precursor of collagen with a 
nonhelical N-terminal portion that may function in the transport of collagen 
from cell to fiber. The application of this interesting concept to the study of 
scleroderma in cell culture is under way in this laboratory. 1360  SCLERODERMA  SKIN  FIBROBLASTS  IN  CELL  CULTURE 
The present study provides direct evidence supporting  the  inference drawn 
from morphologic and collagen solubility studies that collagen synthesis is in- 
creased  in  scleroderma skin.  Also,  the  present  model,  isolated  cells  in  tissue 
culture, provides an optimally controlled setting for studying the mechanism of 
this increased collagen synthesis in  the hope of controlling the presently irre- 
versible fibrosis  of  scleroderma.  Preliminary  studies  suggest  that  the  abnor- 
mality  of  collagen  synthesis  persists  in  scleroderma fibroblasts  after four  or 
more subculture passages. 
After many negative investigations concerning collagen in scleroderma skin, 
including hydroxyproline concentration,  collagen amino acid composition, and 
X-ray  diffraction  (40-42),  it  is  encouraging  that  several  different  types  of 
approach  lead  to  the  conclusion  that  collagen  synthesis  is  increased  in  this 
disorder. 
SUMMARY 
Skin  fibroblasts from subjects  with  scleroderma and  control  subjects  were 
grown  in  tissue  culture  to  compare  the  characteristics  of  connective  tissue 
metabolism.  A  striking  increase  in  soluble  collagen  (media  hydroxyproline) 
was observed in  eight of nine scleroderma cultures when they were compared 
with  identically handled  control  cultures  matched for the  age and  sex of the 
donor  and  the  anatomic site of the  donor skin.  Glycoprotein content  as esti- 
mated  by hexosamine  and  sialic  acid  was  also  significantly  increased  in  the 
sc]eroderma cultures. Estimations of protein-polysaccharide content by uronic 
acid determinations were low in all cultures and not significantly increased in 
scleroderma cultures. 
This  report demonstrates  the  feasibility of using fibroblast cell cultures  to 
stud~  ~ chronic  rheumatic  and  connective  tissue  disorders.  The  initial  results 
suggest  a  net  increase  in  collagen  and  glycoprotein  synthesis  in  scleroderma 
fibroblast  cultures.  The  implications  of  an  abnormality  of  connective  tissue 
metabolism by  skin  fibroblasts propagated  in  vitro  in  the  acquired  disorder 
scleroderma are discussed. 
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